𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients

✍ Scribed by Silva, J M; Dominguez, G; Villanueva, M J; Gonzalez, R; Garcia, J M; Corbacho, C; Provencio, M; España, P; Bonilla, F

Book ID
110002304
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
104 KB
Volume
80
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DNA methylation and expression of p16INK
DNA methylation and expression of p16INK4A gene in pulmonary adenocarcinoma and anthracosis in background lung
✍ Mei Hou; Yukio Morishita; Tatsuo Iljima; Yukinori Inadome; Kentaro Mase; Yuichi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 203 KB 👁 2 views

The p16 (CDKN2/MTS-1/INK4A) tumor-suppressor gene is frequently inactivated by DNA methylation in lung carcinomas. To clarify whether background anthracosis may play a role in DNA methylation and inactivation of the p16 gene, we examined DNA methylation of the p16-promoter region by methylation-spec

TP53 gene mutations in plasma DNA of can
TP53 gene mutations in plasma DNA of cancer patients
✍ Jose M. Silva; Rocio Gonzalez; Gemma Dominguez; Jose M. Garcia; Pilar España; Fe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Using different molecular techniques, DNA has been shown to be present in plasma of patients with several types of tumors. Mutations of TP53 are the most common genetic changes in human cancers. We investigated the presence of TP53 gene mutations in plasma DNA of breast and small cell lung cancer pa

Aberrant methylation of the CDKN2a/p16IN
Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: A prospective study in high-risk patients without invasive cancer.
✍ Aude Lamy; Richard Sesboüé; Jeannette Bourguignon; Brigitte Dautréaux; Josette M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB

## Abstract Among the identified factors involved in malignant transformation, abnormal methylation of the __CDKN2A/p16__^__INK4a__^ gene promoter has been described as an early event, particularly in bronchial cell cancerization. Precancerous bronchial lesions (__n__ = 70) prospectively sampled du